The KRAS Mutation Screening Codons 12 and 13 Test is a specialized diagnostic procedure aimed at detecting mutations in the KRAS gene, specifically in codons 12 and 13. These mutations are significant because they can play a crucial role in the development and progression of various types of cancer, including colorectal, lung, and pancreatic cancers. Identifying mutations in these codons can help in determining the prognosis of the disease and in tailoring personalized treatment plans that are more effective.
The test involves analyzing DNA extracted from a patient's tumor tissue to look for specific alterations in the sequence of the KRAS gene that may promote cancer growth. The results from this test can guide healthcare professionals in making informed decisions about the use of targeted therapies, as some treatments may not work in the presence of a KRAS mutation.
This important diagnostic tool is offered by DNA Labs UAE, a leading facility in genetic testing. The cost of the KRAS Mutation Screening Codons 12 and 13 Test is 2100 AED. By providing access to this test, DNA Labs UAE supports the advancement of personalized medicine and contributes to improving the outcomes for patients with cancer.
The MDS FISH Panel, specifically designed to detect deletions in chromosomes 5q, 7q, and 20q, is a crucial diagnostic test for individuals suspected of having myelodysplastic syndromes (MDS), a group of bone marrow disorders characterized by the bone marrow's inability to produce enough healthy blood cells. This fluorescence in situ hybridization (FISH) test is a powerful cytogenetic technique that allows for the visualization of specific DNA sequences on chromosomes, making it possible to identify chromosomal abnormalities associated with various forms of MDS.
Performing the MDS FISH Panel involves using fluorescent probes that bind to parts of chromosomes 5, 7, and 20. The test can highlight the absence (deletion) of regions in these chromosomes, which are critical markers for diagnosing different subtypes of MDS. Identifying these deletions helps in determining the prognosis, guiding treatment options, and monitoring the response to therapy.
This specialized test is offered by DNA Labs UAE, a leading diagnostic and research facility known for its advanced genetic testing services. The cost of the MDS FISH Panel at DNA Labs UAE is set at 2100 AED, reflecting the comprehensive nature of this diagnostic tool and the sophisticated technology involved in its execution. For patients and healthcare providers, the availability of this test represents an important step in the personalized management of myelodysplastic syndromes, ensuring targeted and effective treatment strategies.
The MGMT Methylation Assay Test is a diagnostic procedure used to assess the methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) gene promoter. This test is particularly significant in the field of oncology, as the methylation of the MGMT gene can influence a patient's response to certain chemotherapy drugs, especially in the treatment of glioblastoma, a type of brain cancer. Methylation of the MGMT promoter silences the gene's expression, affecting the effectiveness of alkylating agents used in chemotherapy by enhancing the sensitivity of cancer cells to these treatments.
Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, the MGMT Methylation Assay Test is priced at 2100 AED. This cost reflects the sophisticated technology and expertise required to accurately determine the methylation status of the MGMT promoter. The results from this assay can provide critical information for personalizing cancer treatment plans, potentially leading to improved outcomes for patients facing certain types of cancer.
The NRAS Mutation Analysis Codons 12 and 13 Test is a specialized genetic test performed to detect mutations in codons 12 and 13 of the NRAS gene. These mutations are significant because they can play a critical role in the development and progression of various types of cancer, including melanoma, colorectal cancer, and others. Identifying these mutations can help in determining prognosis, guiding treatment decisions, and potentially targeting therapies more effectively.
This test is carried out at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The process involves analyzing a sample of DNA, usually extracted from a blood sample or a biopsy of the tumor tissue, to look for specific alterations in the NRAS gene that could drive cancer growth.
The cost of the NRAS Mutation Analysis Codons 12 and 13 Test at DNA Labs UAE is set at 2100 AED. This price reflects the sophisticated technology and expertise required to accurately identify these genetic mutations. For patients and healthcare providers, this test represents a valuable tool in the arsenal against cancer, offering insights that can significantly impact treatment planning and outcomes.
The Pol Gene Mutation Analysis Test, offered by DNA Labs UAE for 2100 AED, is a specialized diagnostic tool designed to identify mutations in the polymerase (pol) gene. This gene plays a crucial role in the replication process of certain viruses, such as HIV and hepatitis B, making this test particularly important in the management and treatment of infections caused by these viruses. By detecting specific mutations, healthcare providers can tailor antiviral therapies more effectively, ensuring that patients receive the most appropriate medication based on their genetic makeup. This precision approach helps in overcoming drug resistance, optimizing treatment outcomes, and improving the overall quality of life for affected individuals. DNA Labs UAE utilizes cutting-edge technology and expertise to deliver accurate and reliable results, supporting both patients and clinicians in the fight against viral diseases.
The "QF PCR Any One Marker and Karyotyping Test" offered by DNA Labs UAE is a comprehensive genetic testing package designed to provide detailed insights into an individual's genetic makeup. This test combines the precision of Quantitative Fluorescence Polymerase Chain Reaction (QF-PCR) for analyzing specific genetic markers, with the broad overview provided by karyotyping.
QF-PCR is a highly sensitive technique used to detect specific genetic abnormalities by amplifying and analyzing small segments of DNA. It is particularly useful for identifying chromosomal anomalies linked to various genetic disorders. Karyotyping, on the other hand, involves examining the entire chromosome set for any structural or numerical changes, offering a broader view of an individual's genetic health.
Together, these methods offer a powerful tool for diagnosing genetic diseases, understanding hereditary conditions, and making informed decisions about health and family planning. The test is priced at 2100 AED, reflecting the comprehensive nature of the analysis and the valuable insights it provides. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and stringent quality standards, clients can expect accurate, reliable results and the support of experienced professionals in interpreting them.
The "RB1 Gene Deletion and Duplication Detection Retinoblastoma Test" is a specialized genetic test offered at DNA Labs UAE, designed to identify deletions or duplications in the RB1 gene. This gene plays a crucial role in the development of retinoblastoma, a rare type of eye cancer that primarily affects young children. Mutations in the RB1 gene can significantly increase the risk of developing this condition. By analyzing the genetic material for any abnormalities in the RB1 gene, this test helps in the early detection and diagnosis of retinoblastoma, enabling timely intervention and treatment. The test is priced at 2100 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of the results.
The Rett Syndrome Deletion and Duplication Detection Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying genetic abnormalities associated with Rett Syndrome, a rare genetic neurological disorder. This test primarily focuses on detecting deletions or duplications in the MECP2 gene, which are common genetic alterations responsible for Rett Syndrome. The MECP2 gene plays a crucial role in the development of the nervous system and brain function, and mutations in this gene can lead to the symptoms associated with Rett Syndrome, including severe cognitive impairments, speech and motor issues, and other neurological problems.
At DNA Labs UAE, this test is conducted using advanced genetic testing techniques to provide accurate and reliable results. The test is priced at 2100 AED, reflecting the sophisticated technology and expertise required to perform the analysis. This test is essential for families seeking a diagnosis for symptoms consistent with Rett Syndrome, as it can confirm the presence of genetic mutations associated with the condition. Early detection through this test can facilitate timely intervention and management strategies to improve the quality of life for individuals affected by Rett Syndrome.
The ROS1 NSCLC Test is a specialized diagnostic assessment designed to detect rearrangements in the ROS1 gene, which are critical for guiding the treatment of non-small cell lung cancer (NSCLC). This molecular testing is pivotal for identifying patients who are likely to benefit from targeted therapy options that specifically inhibit the ROS1 protein. By pinpointing this genetic alteration, healthcare providers can tailor treatment plans that are more effective and potentially have fewer side effects compared to conventional chemotherapy.
Performed at DNA Labs UAE, a facility known for its advanced diagnostic technologies and expert staff, the test ensures high accuracy and reliability. The cost of the ROS1 NSCLC Test is 2100 AED, an investment in precision medicine that can significantly impact the treatment outcomes for patients with NSCLC. This test represents a crucial step in the journey towards personalized cancer therapy, offering hope for improved survival rates and quality of life for patients.
The Adenovirus and Boca Virus Viral Load Quantitative Test is a sophisticated diagnostic procedure designed to accurately measure the amount of adenovirus and Boca virus DNA in a patient's blood or other body fluids. This test is crucial for the early detection, diagnosis, and monitoring of infections caused by these viruses. Adenoviruses are known for causing a range of illnesses, from mild respiratory infections to more severe conditions like pneumonia, while Boca virus is associated with respiratory infections and potentially more serious diseases in immunocompromised individuals.
Performed at DNA Labs UAE, a leading facility in medical diagnostics, the test utilizes advanced molecular techniques to ensure high sensitivity and specificity. The cost of the test is set at 2100 AED, reflecting the comprehensive nature of the analysis and the state-of-the-art technology employed.
By quantifying the viral load, healthcare providers can make informed decisions regarding the necessity of antiviral therapy, monitor the effectiveness of treatment, and predict the patient's prognosis. The test is particularly valuable for patients who are at high risk of severe infections, such as those with weakened immune systems.
DNA Labs UAE is equipped with modern laboratories and staffed by experienced professionals, ensuring that patients receive accurate and reliable results. The facility adheres to stringent quality standards, making it a trusted choice for patients and healthcare providers seeking advanced viral load testing services.
